Rakovec, Maureen
Zhu, William
Khalafallah, Adham M.
Salvatori, Roberto
Hamrahian, Amir H.
Gallia, Gary L.
Ishii, Masaru
London, Nyall R. Jr.
Ramanathan, Murugappan Jr.
Rowan, Nicholas R.
Mukherjee, Debraj https://orcid.org/0000-0002-5403-8237
Article History
Received: 4 May 2022
Accepted: 29 September 2022
First Online: 13 October 2022
Compliance with ethical standards
:
: N. London receives research funding from Merck not related to this study. N. London holds stock in Navigen Pharmaceuticals and was a consultant for Cooltech Inc., neither are related to this study. On behalf of all other authors, the corresponding author states no conflicts of interest.
: This study was reviewed by and received Institutional Review Board approval (IRB00215471).
: Informed consent was obtained from all participants who completed the survey.